Monday, October 5, 2026

Crypto VC Flows Shift to Dubai and Japan as US Regulatory Pressure Mounts, While AI Investment Nears Peak Hype

Venture capital for crypto innovation is migrating from the US to jurisdictions like Dubai, Abu Dhabi, and Japan as SEC enforcement drives companies to geofence American investors. Tim Draper warns AI may be approaching peak hype despite long-term potential in robotics, while new VC infrastructure emerges through platforms like SoFi Alternative Investments and UK's VentureLink program.

Crypto VC Flows Shift to Dubai and Japan as US Regulatory Pressure Mounts, While AI Investment Nears Peak Hype
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Crypto startups are blocking US investors to avoid SEC enforcement, redirecting venture capital flows to Dubai, Abu Dhabi, Japan, and El Salvador. Tim Draper, a prominent crypto investor, says innovators now "geofence the U.S. to protect themselves from the SEC's long arms" after regulators classified most crypto assets as securities.

"The U.S. just decided everything was a security and made it illegal," Draper told Crunchbase News. Countries embracing crypto innovation are capturing deals that would have gone to Silicon Valley. El Salvador's bitcoin adoption and Dubai's crypto-friendly zones now attract projects avoiding US jurisdiction.

Draper advocates reactive regulation over anticipatory rules. "Don't regulate in anticipation of fearful outcomes. Regulate after something bad happens. Otherwise, you put a dark cloud over every innovator," he said.

AI investment may be reaching peak hype despite strong fundamentals. Draper predicts AI "will eventually be bigger than anyone imagined, especially in robotics," but current valuations suggest the market is pricing in best-case scenarios. Quantum computing and robotics are drawing sector-focused capital as investors seek the next wave beyond generative AI.

BMW i Ventures is backing battery technology companies while Alset AI Ventures targets artificial intelligence startups. This specialization marks a shift from the broad AI investment thesis that dominated 2023-2024.

VC infrastructure is evolving to democratize access. SoFi Alternative Investments launched a platform for retail investors to access venture deals previously restricted to institutions. The UK government rolled out VentureLink to connect startups with investors and expanded Enterprise Investment Scheme (EIS) tax incentives.

Draper's decentralization philosophy extends beyond crypto. "The guy at the tiller of the ship knows better than the general in Washington, D.C.," he said, arguing distributed decision-making produces better outcomes than centralized authority.

The regulatory divide creates structural arbitrage opportunities. Funds operating in multiple jurisdictions can capture deals US-based competitors cannot access. Dubai and Singapore are building VC ecosystems specifically targeting projects avoiding US and EU regulatory frameworks.

This fragmentation may persist until global regulatory harmonization occurs or US policy shifts. Until then, capital will continue flowing to jurisdictions offering clearer rules for emerging technologies.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score10 source documents10 with a live linkVerifiability: Strong
  1. [1]News articleCrunchbase News
    Tim Draper On The AI Boom, Bitcoin’s Future And Building ‘Human Accelerators’
  2. [2]Press releaseGlobeNewswire· February 25, 2026
    Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030
  3. [3]Press releaseGlobeNewswire· February 27, 2026
    FullPAC, Inc. Issues Spring 2026 Chairman’s Letter
  4. [4]News articleYahoo Finance· February 25, 2026
    Oak-Eagle AcquireCo, Inc. Announces Pricing Terms for the Previously Announced Tender Offers and Consent Solicitations for Any and All of Electronic Arts Inc.'s 1.850% Senior Notes Due 2031 and 2.950% Senior Notes Due 2051
  5. [5]News articleYahoo Finance· March 4, 2026
    Pasqal, A Global Leader in Neutral Atom Quantum Computing, to Go Public via Business Combination with Bleichroeder Acquisition Corp II
  6. [6]News articleCB Insights
    The top 50 Latin America venture investors in 2026
  7. [7]News articleIEEE Spectrum
    This Offshore Wind Turbine Will House a Data Center Underwater
  8. [8]Press releaseGlobeNewswire· February 25, 2026
    Tokenization Strategic Outlook Report 2025: Emerging Interconnected Digital Ecosystems
  9. [9]Press releaseGlobeNewswire· February 25, 2026
    Vopak reports record financial results for 2025 and announces shareholder distributions program of around EUR 1.7 billion through year-end 2030
  10. [10]Press releaseGlobeNewswire· March 5, 2026
    WISeKey Reports FY 2025 Preliminary Financial Results

In this story

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com